Photo taken from ghealth121.com
Jul 25, 2024, 01:39
An update on the development of HER2-targeted therapies
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X:
“HER2-targeted therapies beyond breast cancer – an update on Nature Reviews Clinical Oncology an update on the current development landscape of HER2-targeted therapies, as well as anticipated future HER2-directed treatment strategies to overcome resistance and thereby improve efficacy and patient outcomes.”
HER2-targeted therapies beyond breast cancer – an update | Nature Reviews Clinical Oncology
Autors: Jeesun Yoon and Do-Youn Oh
Source: Elisabetta Bonzano/X